Erleva 150 mg Tablet
65,16$
53,18$
Erleva 150 mg Tablet is a targeted therapy designed to combat specific types of cancer, primarily non-small cell lung cancer (NSCLC) and pancreatic cancer. Its active ingredient, erlotinib, works by inhibiting the growth of cancer cells by blocking the epidermal growth factor receptor (EGFR), a protein that promotes cell proliferation. This action helps to slow down or stop the spread of cancer, providing a crucial treatment option for patients battling these aggressive forms of the disease. While Erleva can be effective, it’s important to be aware of potential side effects, including skin rash, diarrhea, and liver function changes, which may require monitoring during treatment. Patients should also inform their healthcare provider of any pre-existing conditions or medications to avoid adverse interactions. As with any cancer treatment, adherence to the prescribed regimen and regular follow-up appointments are essential for optimal results. If you or a loved one are facing a cancer diagnosis, consult your healthcare professional to see if Erleva 150 mg Tablet could be a suitable part of your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Erleva 150 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer involves a significant number of lung cells and can present with symptoms such as a persistent cough, chest pain, and shortness of breath. By targeting specific pathways in cancer cells, Erleva helps to slow disease progression and improve overall outcomes. Patients experiencing unexplained weight loss and fatigue may benefit from this targeted therapy.
• In the context of pancreatic cancer, Erleva 150 mg tablet is often used in conjunction with gemcitabine. This combination aims to enhance the effectiveness of treatment for patients battling this aggressive cancer type. Symptoms of pancreatic cancer, including abdominal pain and jaundice, can significantly impact quality of life, and Erleva helps address these challenges. The medication works by inhibiting tumor growth, thus providing a crucial component in the management of this condition.
• Erleva 150 mg tablet is useful for patients who have not responded adequately to other treatments for non-small cell lung cancer. It is designed to target specific genetic mutations that may be present in the cancer cells, offering a more personalized approach to therapy. The use of Erleva can lead to improvements in symptoms such as hoarseness and shortness of breath, allowing patients to engage more fully in daily activities. Its targeted action makes it an important option for managing advanced stages of the disease.
• For patients with pancreatic cancer, Erleva 150 mg tablet can help mitigate some of the debilitating symptoms associated with the disease. When combined with gemcitabine, it provides a strategic approach to treatment that aims to improve patient outcomes. Symptoms like nausea, vomiting, and loss of appetite can be distressing, and the use of Erleva may contribute to better management of these issues. By targeting the cancer more effectively, patients may experience an improved quality of life during their treatment journey.
Benefits
Erleva Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Erleva can help to slow the progression of cancer. Erleva 150 mg Strip may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erleva 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erleva 150 mg Strip can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erleva 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erleva 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erleva 150 mg Strip. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erleva 150 mg Strip is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Erleva 150 mg Tablet is recommended. The use of Erleva 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erleva Tablet. Erleva 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erleva 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erleva Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Erleva 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erleva 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Erleva is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erleva 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved